See accompanying notes to unaudited condensed consolidated financial statements.
See accompanying notes to unaudited condensed consolidated financial statements.
See accompanying notes to unaudited condensed consolidated financial statements.
See accompanying notes to unaudited condensed consolidated financial statements.
See accompanying notes to unaudited condensed consolidated financial statements.
Notes to Unaudited Consolidated Financial
Statements
September 30, 2019
1. NATURE OF OPERATIONS
The Company was only recently formed and
is currently devoting substantially all its efforts in identifying, developing and marketing engineered products, software and
services for applications in the Industrial Internet which involves collecting and processing data collected from a wide variety
of industrial systems and machines.
2. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation
The Company's financial statements are
prepared on the accrual method of accounting. The accounting and reporting policies of the Company conform with generally accepted
accounting principles (“GAAP”).
Interim Financial Statements
The accompanying unaudited condensed interim
financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United
States of America (“U.S. GAAP”) for interim financial information, and in accordance with the rules and regulations
of the United States Securities and Exchange Commission with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited
interim financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion
of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily
indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the
audited financial statements of the Company for the year ended December 31, 2018.
Principles of Consolidation
The consolidated financial statements for
September 30, 2019 include the accounts of IIOT-OXYS, Inc., OXYS Corporation, and HereLab, Inc. All significant intercompany balances
and transactions have been eliminated.
The consolidated financial statements for
September 30, 2018 include the accounts of IIOT-OXYS, Inc., OXYS Corporation, and HereLab, Inc. as of the closing date of the acquisition
agreement dated January 11, 2018. All significant intercompany balances and transactions have been eliminated.
Revenue Recognition
The Company’s revenue is derived
primarily from providing services under contractual agreements. The Company recognizes revenue in accordance with ASC Topic No.
606, Revenue from Contracts with Customers (“ASC 606”) which was adopted on January 1, 2018, using the modified
retrospective method, which was elected to apply to all active contracts as of the adoption date. Application of the modified retrospective
method did not impact amounts previously reported by the Company, nor did it require a cumulative effect adjustment upon adoption,
as the Company's method of recognizing revenue under ASC 606 yielded similar results to the method utilized immediately prior to
adoption. Accordingly, there was no effect to each financial statement line item as a result of applying the new revenue standard.
According to ASC 606, the Company recognizes
revenue based on the following criteria:
|
·
|
Identification of a contract or contracts, with a customer.
|
|
·
|
Identification of the performance obligations in the contract.
|
|
·
|
Determination of contract price.
|
|
·
|
Allocation of transaction price to the performance obligation.
|
|
·
|
Recognition of revenue when, or as, performance obligation is satisfied.
|
The Company used a practical expedient
available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred
before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction
price, and allocating the transaction price to the satisfied and unsatisfied performance obligations.
The Company has elected to treat shipping
and handling activities as cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar
taxes.
Use of Estimates
Management uses estimates and assumptions
in preparing these financial statements in accordance with generally accepted accounting principles. These estimates and assumptions
affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported revenues and expenses during the reporting period. Actual results could vary from the estimates that
were used.
Going Concern
The accompanying financial statements have
been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the
Company was only recently formed, has incurred continuing operating losses and has an accumulated deficit of $4,829,377 and $3,153,020
at September 30, 2019 and December 31, 2018, respectively. These factors raise substantial doubt about the ability of the Company
to continue as a going concern.
Management believes that it will be able
to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next 12 months by generating cash
through additional borrowings and/or issuances of equity securities, as needed. However, there can be no assurance that the Company
will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments
that might result from the outcome of these uncertainties.
3. RECENT ACCOUNTING PRONOUNCEMENTS
ASU 2016-02
In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842). The new standard establishes a right-of-use ("ROU") model that requires a lessee to record
a ROU asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. Leases will
be classified as either finance or operating, with classification affecting the pattern of expense recognition in the consolidated
statement of operations. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, including interim periods
within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees
for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented
in the financial statements, with certain practical expedients available. On January 1, 2019, the Company adopted ASU 2016-02.
The Company is not a lessee of a lease longer than 12 months nor has the Company been a lessee of a lease longer than 12 months
in prior periods therefore there is no impact of the adoption of this standard.
ASU 2018-07
In June 2018, the FASB issued ASU 2018-07,
Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting, which aligned
certain aspects of share-based payments accounting between employees and nonemployees. Specifically, nonemployee share-based payment
awards within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated
to issue when the good has been delivered or the service has been rendered and any other conditions necessary to earn the right
to benefit from the instruments have been satisfied and an entity considers the probability of satisfying performance conditions
when nonemployee share-based payment awards contain such conditions. On January 1, 2019, the Company adopted ASU 2018-17. The new
standard did not have a significant impact on the Company’s financial statements or disclosures.
Other accounting standards that have been
issued or proposed by FASB do not require adoption until a future date are not expected to have a material impact on the consolidated
financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact
on or are unrelated to its financial condition, results of operations, cash flows or disclosures.
4. COMMITMENTS AND CONTINGENCIES
The Company entered into consulting agreements
with one director, three executive officers, and one engineer of the Company throughout the prior year which include commitments
to issue shares of the Company’s common stock from the Company’s Stock Incentive Plans.
According to the agreement with the director,
the shares vest annually over three years at the end of the fiscal year. According to the agreements with the executive officers
and engineer, the shares vest annually over three years on the anniversary of each agreement.
In the event that the agreement is terminated
by either party pursuant to the terms of the agreement, all unvested shares which have been earned shall vest on a pro-rata basis
as of the effective date of the termination of the agreement and all unearned, unvested shares shall be terminated.
The consulting agreement with the director
was terminated upon the resignation of the director on September 20, 2018 and, pursuant to a Settlement Agreement, 104,673 earned
shares were vested. According to the remaining four agreements, 910,000 shares vested in 2019 thus far (with 409,000 shares remaining
to vest in 2019), 2,470,000 shares of common stock will vest in 2020, and 3,680,000 shares of common stock in 2021.
The value of the shares was assigned at
fair market value on the effective date of the agreement and the pro-rata number of shares earned was calculated and amortized
at the end of each reporting period. As of September 30, 2019, 104,673 shares of common were issued to the former director. As
of December 31, 2018, no shares of common stock had been issued to these individuals. The Company accrued $944,467 and $417,229
in shares payable in conjunction with these agreements as of September 30, 2019 and December 31, 2018, respectively. A summary
of these agreements is as follows.
On
June 18, 2018, the Company entered into a Consulting Agreement dated July 1, 2018 with an engineer. The term of the agreement is
for three years beginning as of the effective date, unless terminated earlier pursuant to the agreement. The services to be provided
by the engineer are customary for the position in which the engineer is serving. On October 18, 2018 the Company entered into Amendment
No. 3 to the Consulting Agreement with the engineer consultant. Pursuant to the amendment, the vesting schedule of the equity compensation
awarded to the engineer was clarified and also provided for acceleration of vesting upon the occurrence of a change in control.
As of the effective date of July 1, 2018, the Company shall issue to the engineer an aggregate of 200,000 shares of the Company’s
common stock with vest as follows:
1.
50,000 shares on the first-year anniversary of the effective date;
2.
70,000 shares on the second-year anniversary of the effective date; and
3.
80,000 shares on the third-year anniversary of the effective date.
The shares are issued under the 2017 Stock
Incentive Plan. Vesting of the shares is subject to acceleration of vesting upon the occurrence of certain events such as a Change
of Control (as defined in the agreement) or the listing of the Company’s common stock on a senior exchange. As of September
30, 2019, 50,000 shares had vested.
On March 11, 2019, the Company’s
Board of Directors approved the Consulting Agreement dated effective June 4, 2018 with its CEO. The term of the agreement is for
three years beginning as of the effective date, unless terminated earlier pursuant to the agreement and is automatically renewable
for one-year terms upon the consent of the parties. The services to be provided by the CEO pursuant to the agreement are those
customary for the positions in which the CEO is serving. The CEO shall receive a monthly fee of $15,000 which accrues unless converted
into shares of common stock of the Company at a conversion rate specified in the agreement. Until the Company closes a minimum
$500,000 capital raise, the monthly fee accrues and, upon the closing of such a capital raise, $5,000 of the monthly fee will be
paid to the CEO in cash and the remainder will continue to accrue. Upon the closing of a capital raise of at least $2,000,000,
the entire monthly fee will be paid to the CEO in cash and all accrued and unpaid monthly fees will be paid by the Company within
one year of the closing of such a capital raise. As of the effective date, the Company shall issue to the CEO an aggregate of 3,060,000
shares of the Company’s common stock which vest as follows:
1.
560,000 shares on the first-year anniversary of the effective date;
2.
1,000,000 shares on the second-year anniversary of the effective date; and
3.
1,500,000 shares on the third-year anniversary of the effective date.
The shares are issued under the 2019 Stock
Incentive Plan. Vesting of the shares is subject to acceleration of vesting upon the occurrence of certain events such as a Change
of Control (as defined in the agreement) or the listing of the Company’s common stock on a senior exchange. As of September
30, 2019, 560,000 shares had vested.
On March 11, 2019, the Company’s
Board of Directors approved the Consulting Agreement dated effective October 1, 2018 with its COO. The term of the agreement is
for three years beginning as of the effective date, unless terminated earlier pursuant to the agreement and is automatically renewable
for one-year terms upon the consent of the parties. The services to be provided by the COO pursuant to the agreement are those
customary for the position in which the COO is serving. The COO shall receive a monthly fee of $12,750 which accrues unless converted
into shares of common stock of the Company at a conversion rate specified in the agreement. Until the Company closes a minimum
$500,000 capital raise, the monthly fee accrues and, upon the closing of such a capital raise, $4,250 of the monthly fee will be
paid to the COO in cash and the remainder will continue to accrue. Upon the closing of a capital raise of at least $2,000,000,
the entire monthly fee will be paid to the COO in cash and all accrued and unpaid monthly fees will be paid by the Company within
one year of the closing of such a capital raise. As of the effective date, the Company shall issue to the COO an aggregate of 2,409,000
shares of the Company’s common stock which vest as follows:
1.
409,000 shares on the first-year anniversary of the effective date;
2.
800,000 shares on the second-year anniversary of the effective date; and
3.
1,200,000 shares on the third-year anniversary of the effective date.
The shares are issued under the 2017 Stock
Incentive Plan. Vesting of the shares is subject to acceleration of vesting upon the occurrence of certain events such as a Change
of Control (as defined in the agreement) or the listing of the Company’s common stock on a senior exchange. As of September
30, 2019, no shares had vested.
On March 11, 2019, the Company’s
Board of Directors approved the Amended and Restated Consulting Agreement dated effective April 23, 2018 with its CTO. The term
of the agreement is for three years beginning as of the effective date, unless terminated earlier pursuant to the agreement and
is automatically renewable for one-year terms upon the consent of the parties. The services to be provided by the CTO pursuant
to the agreement are those customary for the position in which the CTO is serving. The CTO shall receive a monthly fee of $9,375
which accrues unless converted into shares of common stock of the Company at a conversion rate specified in the agreement. Until
the Company closes a minimum $500,000 capital raise, the monthly fee accrues and, upon the closing of such a capital raise, $3,125
of the monthly fee will be paid to the CTO in cash and the remainder will continue to accrue. Upon the closing of a capital raise
of at least $2,000,000, the entire monthly fee will be paid to the CTO in cash and all accrued and unpaid monthly fees will be
paid by the Company within one year of the closing of such a capital raise. As of the effective date, the Company shall issue to
the CTO an aggregate of 1,800,000 shares of the Company’s common stock which vest as follows:
1.
300,000 shares on the first-year anniversary of the effective date;
2.
600,000 shares on the second-year anniversary of the effective date; and
3.
900,000 shares on the third-year anniversary of the effective date.
As of September 30, 2019, 300,000 shares
had vested.
5. STOCKHOLDERS' EQUITY
Common Stock
The Company has authorized 190,000,000
shares of $0.001 par value common stock and 10,000,000 shares of $0.001 par value preferred stock. At September 30, 2019 and December
31, 2018, the Company had 43,263,547 and 40,633,327 shares of common stock and no shares of preferred stock issued and outstanding,
respectively.
Holders of shares of common stock are entitled
to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting
rights. Holders of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the
Board of Directors in its discretion from funds legally available, therefore. In the event of liquidation, dissolution, or winding
up of the Company, the holders of common stock are entitled to share pro rata in all assets remaining after payment in full of
all liabilities. All of the outstanding shares of common stock are fully paid and non-assessable. Holders of common stock have
no preemptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund
provisions with respect to the common stock.
On March 16, 2017, the Board of Directors
of IIOT-OXYS, Inc. and a majority of the shareholders of IIOT-OXYS, Inc. approved the IIOT-OXYS, Inc. 2017 Stock Awards Plan, (the
“Plan”). The Plan provided for granted incentive stock options, options that do not constitute incentive stock
options, stock appreciation rights, restricted stock awards, phantom stock awards, or any combination of the foregoing, as is best
suited to the particular circumstances. The Plan was effective upon its adoption by the Board.
The aggregate number of common shares that
may be issued under the Plan were 7,000,000 common shares. No further awards were to be granted under the Plan after ten years
following the effective date. The Plan was to remain in effect until all awards granted under the Plan had been satisfied or expired.
This Plan was terminated and replaced by the 2017 Stock Inventive Plan (the “2017 Plan”) on December 14, 2017
(the “Effective Date”) as approved by the Board of Directors of the Company.
Awards may be made under the 2017 Plan
for up to 4,500,000 shares of common stock of the Company. All of the Company’s employees, officers and directors, as well
as consultants and advisors to the Company are eligible to be granted awards under the 2017 Plan. No awards can be granted under
the 2017 Plan after the expiration of 10 years from the Effective Date but awards previously granted may extend beyond that date.
Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted
stock awards. With the approval of the 2017 Plan, the Board terminated the 2017 Stock Awards Plan with no awards having been granted
thereunder.
On March 11, 2019 (the “Effective
Date”) the Board of Directors of the Company approved the 2019 Stock Incentive Plan (the “Plan”).
Awards may be made under the Plan for up to 5,000,000 shares of common stock of the Company. All of the Company’s employees,
officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the Plan. No
awards can be granted under the Plan after the expiration of 10 years from the Effective Date but awards previously granted may
extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation
rights, and restricted stock awards.
Shares earned and issued related to the
consulting agreements discussed in Note 5 are issued under the 2017 Stock Incentive Plan and the 2019 Stock Incentive Plan. Vesting
of the shares is subject to acceleration of vesting upon the occurrence of certain events such as a Change of Control (as defined
in the agreement) or the listing of the Company’s common stock on a senior exchange.
As of September 30, 2019, and December
31, 2018, there was $1,296,233 and $1,854,873, respectively, of total unrecognized compensation costs related to the non-vested
share-based compensation arrangements awarded to an engineer and consultants. That cost is expected to be recognized over a weighted-average
period of 1.7 years. The total fair value of shares vested during the three and nine months ended September 30, 2019 was $188,260
and $558,640.
Total share-based compensation for the
three and nine months ended September 30, 2019 was $129,902 and $348,110, respectively. Total share-based compensation for the
three and nine months ended September 30, 2018 was $0.
On September 20, 2018, the consulting agreement
with the director was terminated upon the resignation of the director and, pursuant to a Settlement Agreement, 104,673 earned shares
were vested amounting to $21,458. The Company issued these shares on January 1, 2019.
On January 10, 2019, the Company entered
into a Strategic Advisory Agreement with a consultant. The initial term of the agreement is 90 days from the date of the agreement
and will be renewed for an additional 90-day term unless either party gives written notice at least ten days prior to the expiration
of the initial term. Pursuant to the agreement, the consultant provided the Company consulting services pertaining to strategic
planning for marketing and capital raising. In consideration of receipt of the services, the Company issued to the consultant 1,885,547
shares of the Company’s common stock amounting to $249,402 as of September 30, 2019.
On March 7, 2019, the Board of Directors
of the Company approved the Financial Consulting Agreement dated effective March 4, 2019 with a consultant pursuant to which the
Company issued to the consultant 500,000 shares of the Company’s common stock amounting to $60,000 in exchange for consulting
services provided by the consultant to the Company. The term of the agreement is six months, unless terminated earlier.
On March 7, 2019, the Board of Directors
of the Company approved the Settlement Agreement dated effective October 5, 2018 with a consultant pursuant to which the Company
issued to the consultant 65,000 shares of the Company’s common stock amounting to $7,800 in exchange for payment, in full,
for consulting services provided by the consultant to the Company in 2018.
On July 12, 2019 the Board of Directors
of the Company approved an issuance of 25,000 shares of the Company’s common stock amounting to $2,500 to a consultant as
a bonus for services performed.
On September 6, 2019, the Company entered
into a Financial Public Relations Agreement. The term of the Agreement is 45 days from the date of the Agreement and will be renewed
upon written consent of the parties. Pursuant to the Agreement, the consultant will provide the Company consulting services pertaining
to investor relations. In consideration of receipt of the services the Company issued to the consultant 50,000 shares of the Company’s
common stock amounting to $6,950.
6. EARNINGS PER SHARE
The following table sets forth the computation
of basic and diluted net loss per share of common stock for the three and nine months ended September 30, 2019 and 2018:
|
|
For the Three Months Ended September 30,
|
|
|
|
2019
|
|
|
2018
|
|
Net loss
|
|
$
|
(349,316
|
)
|
|
$
|
(243,457
|
)
|
|
|
|
|
|
|
|
|
|
Weighted average share outstanding basic
|
|
|
42,775,966
|
|
|
|
40,633,327
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30,
|
|
|
|
2019
|
|
|
2018
|
|
Net loss
|
|
$
|
(1,676,357
|
)
|
|
$
|
(933,121
|
)
|
|
|
|
|
|
|
|
|
|
Weighted average share outstanding basic
|
|
|
42,005,826
|
|
|
|
40,591,019
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.02
|
)
|
Basic net loss per share is calculated
by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted net loss per share
is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the
period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities
which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the
computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in
the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position.
The following outstanding common stock
equivalents have been excluded from diluted net loss per common share for the three and nine months ended September 30, 2019 and
2018 because their inclusion would be anti-dilutive:
|
|
September 30,
2019
|
|
|
September 30,
2018
|
|
Warrants to purchase common stock
|
|
|
1,315,032
|
|
|
|
384,615
|
|
Potentially issuable shares related to convertible notes payable
|
|
|
4,337,525
|
|
|
|
2,500,000
|
|
Total anti-dilutive common stock equivalents
|
|
|
5,652,557
|
|
|
|
384,615
|
|
7. CONVERTIBLE NOTE PAYABLE
On January 18, 2018, the Board of Directors
of the Company approved a non-public offering of up to $1,000,000 aggregate principal amount of its 12% Senior Secured Convertible
Notes. The notes are convertible, in whole or in part, into shares of the Company’s common stock, at any time at a rate of
$0.65 per share with fractions rounded up to the nearest whole share, unless paid in cash at the Company’s election. The
notes bear interest at a rate of 12% per annum and interest payments will be made on a quarterly basis. The notes mature January
15, 2020.
The notes are governed by a Securities
Purchase Agreement and are secured by all the assets of the Company pursuant to a Security and Pledge Agreement. In addition to
the issuance of the notes in the offering, the Company’s Board of Directors approved, as part of the offering, the issuance
of warrants to purchase one share of the Company’s common stock for 50% of the number of shares of common stock issuable
upon conversion of each note. Each warrant is immediately exercisable at $0.75 per share, contains certain anti-dilution down-round
features and expires on January 15, 2023. If the Company ever defaults on the loan the warrants to be issued will increase from
50% of the number of shares of common stock issuable upon conversion to 100%.
On January 22, 2018, the Company entered
into a SPA and Security and Pledge Agreement with its first investor in the offering and issued a note to the investor in the principal
amount of $500,000. Subscription funds were received by the Company from the investor on February 7, 2018. In addition to the note,
the Company issued to the investor 384,615 warrants. The warrants are considered equity instruments based on the Company’s
adoption of ASU 2017-11.
The proceeds received upon issuing the
note and warrants were allocated to each instrument on a relative fair value basis. The initial fair value of the warrants was
$838,404 determined using the Black-Scholes valuation model with the following assumptions: expected term of 2.5 years; risk free
interest rate of 2.1%; and volatility of 142%. The effective conversion rate resulted in a Beneficial Conversion Feature greater
than the proceeds received. Thus, the discount was limited to the proceeds received of $500,000 and was amortized to interest expense
using the effective interest method over the term of the note.
On March 7, 2019, the Board of Directors
of the Company approved Amendment No. 1 to the 12% Senior Secured Convertible Promissory Note and the Warrant Agreement, each issued
January 22, 2018, respectively, to the note holder. The amendments (i) extend the maturity date of the note to March 1, 2021 and
extend the term of the warrants to March 6, 2024, (ii) lower the conversion price of the note and the exercise price of the warrants
to $0.20 and $0.30, respectively, and (iii) add an adjustment to the conversion and exercise price of the note and warrants, respectively,
in the event the Company does not achieve certain milestones during calendar 2019. The fair value of the warrants is $25,162 determined
using the Black-Scholes valuation model with the following assumptions: expected term of 2.5 years; risk free interest rate of
2.6%; and volatility of 127.4%. The effective conversion rate resulted in a discount of $23,956 and is amortized to interest expense
using the effective interest method over the term of the note. The Company recognized a loss on extinguishment of debt of $221,232
related to the decrease in conversion price.
For the three and nine months ended September
30, 2019 interest expense paid to the investor amounted to $15,123 and $44,877, respectively. For the three and nine months ended
September 30, 2018 interest expense paid to the investor amounted to $15,123 and $41,260, respectively. For the three and nine
months ended September 30, 2019 the Company also amortized to interest expense $3,032 and $50,724, respectively. For the three
and nine months ended September 30, 2018 the Company also amortized to interest expense $63,014 and $171,918, respectively, from
the amortization of the discount.
The unpaid principal balance of the note
is $500,000 at September 30, 2019 and December 31, 2018 and the remaining unamortized discount is $17,069 and $265,068, respectively.
On January 22, 2019, the Company entered
into a Securities Purchase Agreement and Security and Pledge Agreement with a single investor and issued a Secured Convertible
Promissory Note to the investor in the principal amount of $55,000. An aggregate of $54,000 of the subscription funds were received
by the Company from the investor on February 5, 2019 and February 8, 2019. $1,000 of the subscription funds were received by the
Company from the investor on March 26, 2019. In addition to the note, the Company issued to the investor 36,667 warrants. The warrants
are considered equity instruments based on the Company’s adoption of ASU 2017-11.
The proceeds received upon issuing the
note and warrants were allocated to each instrument on a relative fair value basis. The initial fair value of the warrants was
$3,217 determined using the Black-Scholes valuation model with the following assumptions: expected term of 2.5 years; risk free
interest rate of 2.6%; and volatility of 128%. The effective conversion rate resulted in a discount of $3,039 and is amortized
to interest expense using the effective interest method over the term of the note.
For the three and nine months ended September
30, 2019 interest expense paid to the investor amounted to $0. The unpaid principal balance of the note and accrued interest is
$55,000 and $1,891, respectively, at September 30, 2019, the remaining unamortized discount is $953. For the three and nine months
ended September 30, 2019 the Company also amortized to interest expense $760 and $2,086, respectively, from the amortization of
the discount. This note and accrued interest is due to a related party.
On March 7, 2019, the Board of Directors
of the Company approved a non-public offering of up to $500,000 aggregate principal amount of its 12% Senior Secured Convertible
Notes. The notes are convertible, in whole or in part, into shares of the Company’s common stock, at any time at a rate of
$0.20 per share with fractions rounded up to the nearest whole share, unless paid in cash at the Company’s election. The
notes bear interest at a rate of 12% per annum and interest payments will be made on a quarterly basis. The notes mature March
1, 2021. The conversion price of the notes is also subject to adjustments if the Company does not achieve certain milestones during
the calendar year 2019.
The notes are governed by a Securities
Purchase Agreement and are secured by all the assets of the Company pursuant to a Security and Pledge Agreement. Funding is subject
to the occurrence of certain milestones, as stated in the SPA. In addition to the issuance of the notes in the offering, the Company’s
Board of Directors approved, as part of the offering, the issuance of warrants to purchase one share of the Company’s common
stock for 50% of the number of shares of common stock issuable upon conversion of each note. Each warrant is immediately exercisable
at $0.30 per share and expires five years from the issuance date.
On March 6, 2019, the Company entered into
SPAs and Security and Pledge Agreements with its first two investors in the offering and issued notes to the investors in the aggregate
principal amount of $100,000. Subscription funds were received by the Company from the investors on March 6, 2019. In addition
to the notes, the Company issued to the investors an aggregate of 250,000 warrants. The warrants are considered equity instruments
based on the Company’s adoption of ASU 2017-11.
The proceeds received upon issuing the
notes and warrants were allocated to each instrument on a relative fair value basis. The initial fair value of the warrants was
$12,646 determined using the Black-Scholes valuation model with the following assumptions: expected term of 2.5 years; risk free
interest rate of 2.5%; and volatility of 127%. The effective conversion rate resulted in a discount of $11,226 and is amortized
to interest expense using the effective interest method over the term of the notes.
The unpaid principal balance of the notes
is $100,000 and the balance of the unamortized discount is $4,843 at September 30, 2019. Interest expense paid to the investors
amounted to $3,025 and $6,838 for the three and nine months ended September 30, 2019, respectively. For the three months and nine
months ended September 30, 2019, the Company also amortized to interest expense $2,807 and $6,383, respectively, from the amortization
of the discount.
On August 2, 2019, the Company entered
into a Securities Purchase Agreement with an investor for the purchase of a 12% Secured Convertible Note in the principal amount
of up to $125,000. The note is convertible, in whole or in part, into shares of the Company’s common stock, at any time at
a rate of $0.08 per share with fractions rounded up to the nearest whole share, unless paid in cash at the Company’s election.
The note bears interest at a rate of 12% per annum and interest payments will be made on a quarterly basis. The note matures August
2, 2021. $75,000 and $25,000 subscription funds were received by the Company from the investor on August 2, 2019 and September
6, 2019, respectively. In addition to the note, the Company issued to the investor an aggregate of 468,750 warrants. The warrants
are considered equity instruments based on the Company’s adoption of ASU 2017-11.
The proceeds received upon issuing the
note and warrants were allocated to each instrument on a relative fair value basis. The initial fair value of the warrants was
$21,076 determined using the Black-Scholes valuation model with the following assumptions: expected term of 1.0 years; risk free
interest rate of 1.7%; and volatility of 122%. The effective conversion rate resulted in a Beneficial Conversion Feature greater
than the proceeds received. Thus, the discount was limited to the proceeds received of $100,000 and was amortized to interest expense
using the effective interest method over the term of the note.
The unpaid principal balance of the notes
is $100,000 and the balance of the unamortized discount is $91,929 at September 30, 2019. Interest expense paid to the investor
amounted to $1,652 for the three and nine months ended September 30, 2019. For the three months and nine months ended September
30, 2019, the Company also amortized to interest expense $8,071 from the amortization of the discount. This note is payable
to and the interest expense was paid to a related party.
On August 29, 2019 (the “Issue
Date”), the Company entered into a Securities Purchase Agreement with an investor for the purchase of a Convertible Promissory
Note in the principal amount of up to $105,000. The Note is not convertible within 180 days of receipt of funds for the first closing
and is then convertible, in whole or in part, into shares of the Company’s Common Stock at a rate of $0.20 per share. Upon
an “Event of Default,” as defined in the note, the conversion price becomes the “Variable Conversion Price”
which is defined in the note as “60% multiplied by the Marked Price.” “Market Price” is defined in the
note as “the lowest one (1) Trading Price (as defined in the note) for the common stock during the twenty-five (25) Trading
Day period ending on the last complete Trading Day prior to the Conversion Date.” The note bears interest at a rate of 10%
per annum with principal and accrued and unpaid interest payable one year from the receipt of funds for each tranche under the
note. Subscription funds of $30,000 were received by the Company from the investor on September 6, 2019 for which the Company paid
a purchase price of $35,000. In addition to the notes, the Company issued to the investor an aggregate of 175,000 warrants. The
warrants are considered equity instruments based on the Company’s adoption of ASU 2017-11.
The proceeds received upon issuing the
notes and warrants were allocated to each instrument on a relative fair value basis. The initial fair value of the warrants was
$3,430 determined using the Black-Scholes valuation model with the following assumptions: expected term of .25 years; risk free
interest rate of 1.9%; and volatility of 132%. The effective conversion rate resulted in a discount of $3,078 and is amortized
to interest expense using the effective interest method over the term of the notes.
The unpaid principal balance of the notes
is $35,000 and the balance of the unamortized discount is $7,672 at September 30, 2019. Interest expense accrued amounted to $230
as of September 30, 2019. For the three months and nine months ended September 30, 2019 the Company also amortized to interest
expense $1,065 from the amortization of the discount.
8. RELATED PARTIES
At September 30, 2019 and December 31,
2018, the amount due to stockholders was $1,000. The balance is payable to two stockholders related to opening bank balances.
At September 30, 2019 and December 31,
2018 accounts payable due to three officers was $600,077 and $237,514, respectively which is represented in accounts payable on
the consolidated balance sheets. The majority of the balance is related to deferred salary expenses while the remainder is related
to reimbursable expenses that were incurred throughout the year.
In January 2018 the Company entered into
a lease agreement with a stockholder of the Company and paid monthly installments of $2,000 which terminated on December 31, 2018.
The Company renewed the lease agreement in January 2019 for monthly installments of $2,000 which terminated on June 30, 2019, the
Company now rents month to month. For the three and nine months ended September 30, 2019 and 2018, rent expense paid to the stockholder
amounted to $6,000 and $18,000, respectively.
The Company entered into a verbal arrangement
in June of 2017 with a company controlled by a shareholder to provide administrative services. Total payments to the related party
for administrative services amounted to approximately $0 for the three and nine months ended September 30, 2019 and approximately
$0 and $26,000, for the three and nine months ended September 30, 2018, respectively.
For the three and nine months ended September
30, 2019 professional expense paid to directors and officers of the Company amounted to $0. For the three and nine months ended
September 30, 2018, professional expense paid to directors and officers of the Company amounted to approximately $7,200 and $57,400,
respectively. For the three and nine months ended September 30, 2019, travel expense paid on behalf of directors and officers of
the Company amounted to approximately $0. For the three and nine months ended September 30, 2018, travel expenses paid on behalf
of directors and officers of the Company amounted to approximately $0 and $10,000, respectively.
9. SUBSEQUENT EVENTS
The Company has evaluated subsequent events
from the balance sheet date through the date the financial statements were issued and determined that there was nothing material
to disclose.